Our data indicate that protective Hif-1α mediated NO is at least partially regulated by the key proinflammatory mediator Il-1β, increasing our understanding of the mechanism of action of the potential therapeutic target, Hif-1α, as a host-derived factor in TB. The gene discussed is IL1B; the disease is tuberculosis.